Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and predniso (Q46886613)
Jump to navigation
Jump to search
scientific article published on 10 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and predniso |
scientific article published on 10 January 2006 |
Statements
1 reference
Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and predniso (English)
1 reference
W Pönisch
1 reference
P S Mitrou
1 reference
K Merkle
1 reference
M Herold
1 reference
M Assmann
1 reference
G Wilhelm
1 reference
K Dachselt
1 reference
P Richter
1 reference
V Schirmer
1 reference
A Schulze
1 reference
R Subert
1 reference
B Harksel
1 reference
N Grobe
1 reference
E Stelzer
1 reference
M Schulze
1 reference
A Bittrich
1 reference
M Freund
1 reference
R Pasold
1 reference
Th Friedrich
1 reference
W Helbig
1 reference
D Niederwieser
1 reference
East German Study Group of Hematology and Oncology (OSHO)
1 reference
10 January 2006
1 reference
132
1 reference
4
1 reference
205-212
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference